TABLE 2.
Comparison of coreceptor usage by clones from plasma and culture supernatanta
| Patient no. | Age (months) | No. of clones from plasma
|
No. of clones from PBMC supernatant
|
||||
|---|---|---|---|---|---|---|---|
| R5 | X4 | R5X4 | R5 | X4 | R5X4 | ||
| 145 | 5 | 11 | 0 | 0 | 11 | 0 | 0 |
| 48 | 1 | 4 | 4 | 0 | 2 | 6 | |
| 67 | 5 | 0 | 6 | 0 | 1 | 8 | |
| 136 | 3 | 11 | 0 | 0 | NA | NA | NA |
| 34 | 12 | 0 | 0 | NA | NA | NA | |
| 60 | 11 | 1 | 0 | 1 | 6 | 4 | |
| 64 | 6 | 3 | 1 | 2 | 3 | 5 | |
a
Comparison is of the number of clones carrying an envelope sequence from plasma samples and from PBMC culture supernatant, characterized by specific coreceptor usage. NA, sample not available.